Boston, MA 06/03/2014 (wallstreetpr) – The leading pharmaceutical company ITonis Inc. (OTCMKTS:ITNS) recently announced that US Food & Drug Administration finally approved NDC number (National Drug Code) for the production of Emesyl(R) Product.
Details:
It means that now ITonis Inc. (OTCMKTS:ITNS) can produce and market Emesyl(R) in all over the world. Please note that NDC number of the product was 59067-001. Company can now sell & market this over the counter homeopathic product without any hassle.
Other than the approval from FDA, ITonis Inc. (OTCMKTS:ITNS) also received a notice from U.S. Patent & Trademark Office. The notice was given in regard with the allowance of trademark of newly launched Emesyl(R) Product. ITNS has given the responsibility of manufacturing to its sister concern Oasis Health Products. As ITNS has received NDC number and trademark approval from the government, so it can immediately start the product packaging and designing.
The company can now start marketing the product in all over the country. The first point of contact will be the retailers i.e. drugstore retailers, cruise lines, department stores, and other small and large strategic retail sectors. The company is trying its best to place Emesyl(R) as one of the best over the counter pharmaceutical products on the global level.
When asked from the inventor of Emesyl(R) Dr. Charles H. Hensley, about the future prospects of the product, he said,” We have wasted no time in promoting the manufacturer of Emesyl(R). Our main objective is to bring this product as soon as possible in the market.” Please note that there was a need of prescription way 30 years back to more than 700 OTC products that are available in the market today. If you have OTC pharmaceutical products available with you, then the need of doctor’s visit decreases significantly. It is the main reason as why the company is trying to make Emesyl(R) Product available in the market as soon as possible.
